The services offer improved convenience and potentially improved patient outcomes and will be key to facilitating expected upticks in telehealth and remote testing.
Intermountain Healthcare Rolling Out Galleri Multi-Cancer Early Detection Test in Pilot Program
Premium
The test is first available to employees over age 50 covered under Intermountain's SelectHealth, but the health system has a bigger five-year plan.
As the firm continues to develop assays to run on a current batch-based MDx system, it seeks to develop a more flexible, random-access testing platform.
FDA Issues First EUA for Non-Prescription COVID-19/Flu/RSV Test
The sample kit can be purchased online or in a store without a prescription with users self-collecting nasal swab samples and mailing them to the lab.
The firm launched its Accelerate Arc platform at the end of Q1 and plans to roll out its Pheno II system in 2024.
Lucence Publishes Clinical Validation of LiquidHallmark Circulating Tumor DNA Test, Expands to RNA
Premium
The firm plans to ramp up US commercialization following the study, while continuing to develop its cell-free RNA diagnostic platform.
Although the firm remains in the red, the new CEO is counting on testing volume growth, health system partnerships, and operational efficiencies including layoffs to reach profitability.